News & Analysis as of

Research and Development Federal Funding Medical Research

Wiley Rein LLP

Capping It All Off: NIH Caps Indirect Rates for Grants

Wiley Rein LLP on

SUMMARY: On February 7, 2025, the Office of the Director for the National Institutes of Health (NIH) issued a Notice (Notice No. NOT-OD-25-068) imposing a cap of 15% on the indirect cost rates that can be charged to the...more

Holland & Knight LLP

New Requirements for Research Security Programs Raise the Stakes for Compliance

Holland & Knight LLP on

The National Security Presidential Memorandum-33 (NSPM-33), issued in January 2021, directed federal agencies that fund research and development (R&D) projects to require certain "Covered Institutions" to certify that the...more

Health Care Compliance Association (HCCA)

Report on Research Compliance Volume 18, Number 9. In This Month’s E-News: September 2021

Report on Research Compliance 18, no. 9 (September, 2021) - A former Harvard Medical School and Massachusetts General Hospital (MGH) researcher who was the principal investigator on a 2014 NIH award of $939,495.27 and...more

White & Case LLP

Launch of the Future Fund: Funding for the UK's fast-growth companies

White & Case LLP on

On 20 April 2020, the Chancellor of the Exchequer announced a scheme aimed at providing support to the UK's most innovative and fastest-growing companies. Below we provide an overview of the scheme and highlight some key...more

Health Care Compliance Association (HCCA)

NSF OIG Deploys 'Redesigned' Audit Approach: Assess the 'Environment,' Then Target Inquiries

Report on Research Compliance 17, no. 3 (February 20, 2020) - Institutions with federal research dollars, particularly from the National Science Foundation (NSF), know they may be subject to an audit by the funding...more

Ballard Spahr LLP

Obama Signs 21st Century Cures Act, Adding $6.3 Billion For Medical Research

Ballard Spahr LLP on

The Cures Act aims to increase the speed by which new drugs are brought to market by streamlining clinical trials, allowing the use of patient data in the regulatory review process, and modernizing U.S. Food and Drug...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide